Organization: Univ of Toronto

Spin-off targets new market for stem cells

A new Montreal biotech company has been launched to commercialize a technology that would overcome the shortage of bone marrow donors for patients with acute myeloid leukemia. Launched by the Institute for Research in Immunology and Cancer – Commercialization of Research and the Centre for Commercialization of Regenerative Medicine, ExCellThera is based on a proprietary…

NSERC awards $28 million in CREATE grants

The Natural Sciences and Engineering Research Council is providing graduate and post-doctoral training grants of $1.65 million to 17 research teams through its Collaborative Research and Training Experience (CREATE) program. The $28 million in awards range from materials for enhanced energy technologies at the Univ of Victoria and advanced network systems for intelligent transportation at…

NSERC Discovery Frontiers short list announced

The Natural Sciences and Engineering Research Council (NSERC) has released a short list of six proposals for its Discovery Frontiers competition. The fund provides $1 million annually over four years to successful applicants. Projects submitting full proposals are: New Materials for Clean Energy and Enhanced Energy Efficiency from Heavy Oil and Oil Sands Reservoirs (Univ…

NSERC Discovery Frontiers short list announced

The Natural Sciences and Engineering Research Council (NSERC) has released a short list of six proposals for its Discovery Frontiers competition. The fund provides $1 million annually over four years to successful applicants. Projects submitting full proposals are: New Materials for Clean Energy and Enhanced Energy Efficiency from Heavy Oil and Oil Sands Reservoirs (Univ…

CRC announces $139 million for 150 research chairs

The Canada Research Chairs (CRC) program has announced 150 new and renewed chairs at 36 post-secondary institutions, with the Univ of Toronto leading the pack with $17.6 million for 19 chairs. The awards are worth $139 million and are augmented with $7.6 million in infrastructure support from the Canada Foundation for Innovation. With the latest…

CRC announces $139 million for 150 research chairs

The Canada Research Chairs (CRC) program has announced 150 new and renewed chairs at 36 post-secondary institutions, with the Univ of Toronto leading the pack with $17.6 million for 19 chairs. The awards are worth $139 million and are augmented with $7.6 million in infrastructure support from the Canada Foundation for Innovation. With the latest…

ChipCare finalizes $5-million series A financing

ChipCare Corp has closed a $5-million series A financing to bring its handheld, blood-testing platform for HIV and other infectious and non-communicable diseases to market. Financing for the Univ of Toronto start-up was led by Puffin Partners LP, Dallas TX, and includes MaRS Innovation, Maple Leaf Angels, Winfield Venture Group, Epic Capital and US and…

ChipCare finalizes $5-million series A financing

ChipCare Corp has closed a $5-million series A financing to bring its handheld, blood-testing platform for HIV and other infectious and non-communicable diseases to market. Financing for the Univ of Toronto start-up was led by Puffin Partners LP, Dallas TX, and includes MaRS Innovation, Maple Leaf Angels, Winfield Venture Group, Epic Capital and US and…

Merck joins SGC, contributes $7.5 million

Merck & Co Inc is contributing $7.5 million to the Structural Genomics Consortium (SGC) as its newest corporate member. Merck’s decision to join the SGC was prompted by the organization’s status as a public-private partnership and its pioneering efforts to use open source intellectual property for moving technologies and medications into proprietary drug discovery programs.…

Merck joins SGC, contributes $7.5 million

Merck & Co Inc is contributing $7.5 million to the Structural Genomics Consortium (SGC) as its newest corporate member. Merck’s decision to join the SGC was prompted by the organization’s status as a public-private partnership and its pioneering efforts to use open source intellectual property for moving technologies and medications into proprietary drug discovery programs.…